Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS.
Lemal R, Fouquet G, Terriou L, Vaes M, Livideanu CB, Frenzel L, Barete S, Canioni D, Lhermitte L, Rossignol J, Arock M, Dubreuil P, Lortholary O, Hermine O.
Lemal R, et al. Among authors: vaes m.
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2387-2395.e3. doi: 10.1016/j.jaip.2019.03.039. Epub 2019 Apr 5.
J Allergy Clin Immunol Pract. 2019.
PMID: 30954641
Clinical Trial.